@oae-evcna.bsky.social🧬How do #EVs shape the tumor microenvironment?
This study highlights exosomal LYPLAL1-DT as a mediator of bidirectional communication between small cell #lungcancer and endothelial cells, promoting tumor progression and angiogenesis. 🧬
www.oaepublish.com/articles/evc...
@goetzjacky.bsky.social
@btog.bsky.socialKey takeaway from our 2026 Conference: Malnutrition incidence in lung cancer patients at NCCC outpatient clinic. Full details for members. #LCSM #lungcancer
@thecancersurvivorsclub.comEncouraging lung cancer results: Imdelltra plus Imfinzi significantly improved overall survival in a late-stage trial for extensive-stage small-cell lung cancer.
@bryanchristian.bsky.socialScientists make concerning discovery about lung cancer and microplastics
www.independent.co.uk/news/health/...
#Health #Lungs #Cancer #LungCancer #Microplastics #PlasticPollution #Study
@lcrf.orgWhen Glenna’s initial #LungCancer treatment failed, biomarker testing gave her doctors the key to a targeted treatment. Today, she has no evidence of disease.
In 2023 – when Glenna was diagnosed – only 2 treatments were approved for HER2+ NSCLC. Now, thanks to research, there are 4. LCRF.org/fall26
@ccsresearch.bsky.social#LungCancer often arises in narrow, fragile spaces deep in the lungs. These tumours can be hard to biopsy – so Chukwudozie Ubosi is developing a tiny robotic device made of soft materials. Using AI-assisted magnetic steering to navigate the lung, the robot will enable easier, safer #cancer biopsies.
@ccsresearch.bsky.socialWildfire smoke exposure is linked to higher #LungCancer risk and lower survival rates. Kenneth Ofori-Amanfo is studying how lung cells react to smoke and how this contributes to #cancer risk. The work could eventually lead to better prevention and new targeted treatments for people with lung cancer.
@oncoalert.bsky.socialFDA News🇺🇸 Sevabertinib Approved in Locally Advanced #NSCLC #LungCancer
On September 9, 2026, the FDA granted accelerated approval to sevabertinib (Hyrnuo) for adults with locally advanced or metastatic non-squamous NSCLC harboring HER2 (ERBB2) TKD activating mutations
@lungcancereurope.bsky.socialThank you @europeanrespsoc.bsky.social for an excellent #ERSCongress2026 in Barcelona.
We presented 2 abstracts, contributed to discussions on #lungcancer & made new connections across respiratory health.
Read our round-up:
lungcancereurope.eu/news/lung-ca...
@alkpositiveuk.bsky.socialScotland has confirmed routine NHS access to lorlatinib after previous ALK+ lung cancer treatment.
It had been available on an interim basis since 2020. Following reassessment and further evidence, that access is now routine.
@healthcare-europe.bsky.social🫁 People with #lungcancer are more likely to have #microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to new research from 🇮🇪 @ucdmedicine.bsky.social, presented at the @europeanrespsoc.bsky.social's #ERSCongress.
@btog.bsky.socialKey takeaway from our 2026 Annual Conference: Lung cancer in never smokers at Guy's Cancer Centre by Alexandra Holdich. Full recordings available to members. #LCSM #lungcancer
@lungcancereurope.bsky.socialFrom today’s #ERSCongress2026 poster session: SCLC survey.
❌ 19/37 were offered no support
🩺 24/37 reported doctor-led decisions
🧪 1/37 reported clinical trial discussions
People with #LungCancer must be part of the conversation.
@oncologynurseadv.bsky.socialNew research explores using SABR and low-dose radiation for widespread polymetastatic disease to improve local control & prime immune responses for patients with #LungCancer and #ProstateCancer!
Read the full article here: https://bit.ly/4iA1Y9t
@lcrf.orgThank you to Abbvie for your generosity and support as a National Presenting Sponsor for the Free to Breathe events program! #FreeToBreathe #LungCancer #ThankYou
@estroradiotherapy.bsky.socialMyth vs. Fact in Small Cell #LungCancer! 💡
For #WRAD2026, Dr Nicolas Pourel breaks down modern #SCLC treatment: #IMRT/#VMAT, low side effects, dose escalation & #ImmunoOncology.
🎥 Watch: https://bit.ly/467gmhZ
#Radonc #LungCancer
@lcrf.orgWhen you register for the Free to Breathe Anywhere Walk, you'll receive a kit in the mail with your own LCRF butterfly, a t-shirt (when you raise $100), and some other goodies. Register by September 21 in order to receive your kit in time for our National Walk Weekend! LCRF.org/anywhere #LungCancer
@southamptonctu.bsky.socialToday is #WorldRadiotherapyAwarenessDay.
We're highlighting some of our staff who are working on the TOURIST Platform Trial, the world's largest #ClinicalTrial using radiotherapy in the treatment of metastatic #LungCancer.
Swipe through the images below 👇 and find out more at bit.ly/3K5GVMO
@alkpositiveuk.bsky.socialIt’s #WorldRadiotherapyAwarenessDay.
Radiotherapy can also play an important role in ALK+ #lungcancer. It may be used to treat cancer in the brain or other parts of the body, control one or a small number of areas that have started growing, or relieve symptoms.
